About Us

At ProdIgY Biotech

We are pioneering IgY-based antibody therapeutics to revolutionize the treatment of liver diseases through microbiome modulation. Our cutting-edge research and technology harness the unique properties of avian-derived antibodies to selectively neutralize harmful microbial components while preserving beneficial gut flora. By targeting the gut-liver axis, we aim to develop first-in-class, non-invasive therapies that address the root causes of alcohol-associated hepatitis (AH).